EpigeneticLock.com — available for acquisition

A PREMIUM BRAND ASSET IN LONGEVITY SCIENCE.

The domain. The site. The content system. The brand.


View the Asset ↓Enquire →

$85B

Longevity biotech market 2025

$182B

Projected by 2034

15.3%

Epigenetics CAGR to 2034

552

Active clinical trials in epigenetics

Market

Aging-related diseases account for over 70% of all deaths in high-income countries.

Epigenetic reprogramming therapy alone is projected to grow from $890M in 2025 to $6.84B by 2034 at a CAGR of 24.3% — the fastest sub-segment in all of biotech.

Epigenetic Reprogramming Therapy Market Report — marketintelo.com (2026)


CAGR 24.3%, $890M → $6.84B by 2034. Life Biosciences Phase 1 trial (ER-100) initiated Q1 2026. marketintelo.com/report/epigenetic-reprogramming-therapy-market ↗ .


What is Epigenetics?

Towards Healthcare / Precedence Research (Sept 2025, GlobeNewswire)

Epigenetics market $19.55B in 2025 → $81.32B by 2034, CAGR 15.32%. 552 active ClinicalTrials.gov epigenetics studies as of May 2025. 8 FDA-approved epigenetic therapies. globenewswire.com — epigenetics market Sept 2025 ↗


What is Epigenetics?

Fortune Business Insights (2026)

Epigenetics market $19.67B in 2025 → $72.31B by 2034, CAGR 15.56% — corroborating figure from a second major analyst. fortunebusinessinsights.com/epigenetics-market ↗


What is Epigenetics?

Industry Dynamics

Why Now?

2006

Yamanaka discovers OSKM factors


four transcription factors (OCT4, SOX2, KLF4, c-MYC) can reprogram adult cells back to a stem-like state, reversing their developmental age. Nobel Prize 2012.

2020

Partial reprogramming in living animals


OSK (without c-MYC) reverses epigenetic age in mouse retinal cells without losing cell identity. Proof the lock can be partially unlocked safely.

2024

OSK extends mouse lifespan 109%


systemically delivered gene therapy in 124-week-old mice (very old) more than doubled remaining lifespan. Published NIH/PMC.

2026

FDA clears first human trial


Life Biosciences' ER-100 (OSK gene therapy) receives IND clearance in January 2026. The first epigenetic reprogramming therapy enters human clinical trials. Backed by David Sinclair, Harvard.

Sources: Longevity.Technology — FDA clears ER-100, Jan 2026 ↗  ·  NIH/PMC — OSK extends lifespan 109% ↗  ·  NIH/PMC — Chemical reprogramming ↗

WHY THIS DOMAIN

EpigeneticLock.com takes its name from this established biological mechanism —
stable silencing of gene states
through heterochromatin—

now at the centre of the FDA's first human epigenetic reprogramming trial, cleared January 2026.



The trial marks the first clinical test of epigenetic age reversal in humans —
the point at which a field valued at $9.86B transitions
from laboratory research into medicine.

Asset

- What's included? -

Visit EpigeneticLock.com ↗

EpigeneticLock.com

A two-word, exact-match .com in the epigenetic science and longevity space.

The domain takes its name from an established biological mechanism — and a scientific term positioned at the frontier of therapeutic research.


As the field advances, the name advances with it.

Registered · Live · Indexed by Google Organic impressions confirmed in Search Console

Sources: Longevity.Technology — FDA clears ER-100, Jan 2026 ↗  ·  NIH/PMC — OSK extends lifespan 109% ↗  ·  NIH/PMC — Chemical reprogramming ↗


What is Epigenetics?

Brand

A distinctive, ownable name in a sector still minting its vocabulary. "Lock" is immediately understood, scientifically grounded, and visually ownable — no competing .com exists.


What is Epigenetics?

A structured educational site

built across nine layers of epigenetic science — clocks, methylation, nutrition, exercise, circadian biology, longevity pathways, reprogramming, research infrastructure, and mind-body practice. Original custom infographics. Primary-source citations throughout. A buyer inherits months of content work.


What is Epigenetics?

A Complete User Journey — Built

The site guides a complete stranger from zero to informed in under 10 minutes:
New to biological age? → Can I Influence It? → How to Measure? → Can It Be Reversed?
That narrative arc — curiosity to action to frontier science — is already built, tested, and live. A buyer inherits a content system with a clear user story, not a blank page.


What is Epigenetics?

Original Custom Infographics

Yamanaka factors, partial reprogramming, the clock/lock distinction — visualised in a consistent premium aesthetic. Not stock. Not generic. Ownable visual IP that travels with the brand.


What is Epigenetics?

Inquiries & Correspondence